May 12, 2024

Revolutionizing Medicine: DoseMeRx's Journey to Smarter Dosing!

Paul Edwards is the President and CEO of DoseMeRx. He has been a Senior Executive with Merck and GSK, and start-ups including ILUM Health Solutions, Infectious Disease Connect, and TrackMy Solutions. He has an extensive history in infectious disease,...

Paul Edwards is the President and CEO of DoseMeRx. He has been a Senior Executive with Merck and GSK, and start-ups including ILUM Health Solutions, Infectious Disease Connect, and TrackMy Solutions. He has an extensive history in infectious disease, antimicrobial stewardship, and precision medicine.

 

  • Guest Introduction: Paul Edwards, the President and CEO of DoseMeRx, shares his extensive background in the pharmaceutical industry, including roles at Merck, GSK, and various startups, focusing on antibiotics and infectious diseases.

  • Pharmaceutical Journey: Paul discusses his career progression from selling macrolides to leading infectious disease units and moving to the U.S. to transform commercial models at Merck, emphasizing the importance of real-world data over clinical trial data.

  • DoseMeRx Focus: DoseMeRx specializes in precise dosing for critically ill patients using therapeutic drug monitoring, particularly for injectable antibiotics, aiming to provide accurate dosing information through web-based and integrated models within hospital systems.

  • Challenges and Future of Medicine: Paul highlights the importance of antimicrobial stewardship, pharmacogenomics, and personalized medicine in improving patient care and expresses concerns about the current insurance and payment systems based on actuarial science.

Please check out our Life Science Success Resources.  You will find tools that will support growing companies and books for authors I have interviewed.  

Paul Edwards Profile Photo

Paul Edwards

President & CEO

Paul has been a Senior Executive with Merck and GSK, and start-ups including ILUM Health Solutions, Infectious Disease Connect, and TrackMy Solutions. He has an extensive history in infectious disease, antimicrobial stewardship, and precision medicine. He has led strategic and operational teams that have implemented antimicrobial stewardship programs in many countries around the world, most notably the United States, United Kingdom, India, South Africa, and Colombia. It is with this global perspective that Paul understands the critical importance of how Bayesian dosing software can have a significant impact on both patient and hospital outcomes. Paul holds an MBA from Oxford Brookes University in the UK. He lives in Jupiter, Florida with his wife Dianne.